AI in imaging Intrasense combines clinical imaging expertise with AI algorithms across oncology and lesion detection, presenting opportunities to upsell AI-powered analytics and decision-support modules to radiology departments and cancer centers leveraging Myrian and DUOnco.

Strategic parent As a digital subsidiary of Guerbet since 2023, Intrasense can leverage Guerbet’s established customer base, distribution channels, and cross-sell opportunities for integrated imaging software within hospitals adopting Guerbet imaging hardware and workflows.

Regulatory maturity With ISO 13485 certification and CE-marked AI offerings, Intrasense can target hospitals and clinics seeking compliant, enterprise-grade imaging software, reducing procurement risk and accelerating purchasing cycles for new platforms.

SME-focused scale Operating with 51-200 employees and annual revenue in the low single-digit millions, Intrasense presents a compelling target for pilots, value-based licensing, and modular subscription plans to accelerate footholds in mid-sized radiology groups and oncology centers.

Product-led expansion A broad portfolio including Myrian (visualization), DUOnco (AI oncology detection), and Liflow (longitudinal monitoring) creates multiple entry points for cross-sell and upsell within existing customers and healthcare systems pursuing end-to-end imaging workflows.